Daewoong Pharmaceutical Co. LTD.: all 225 studies

Page 1 of 3. Open to participants first (35), then studies with results posted, then the rest; newest registration first within each.

• Study of DWP450 in Japanese Subjects With Glabellar LinesNot yet recruitingNCT07783763Phase 3
• Efficacy and Safety of DWP14012 for Long-Term Maintenance Therapy in Patients With Healed Erosive EsophagitisNot yet recruitingNCT07746518Phase 3
• Phase 3 to Evaluate the Efficacy and Safety of DWP14012 in Patients With Gastric UlcerNot yet recruitingNCT07730138Phase 3
• To Evaluate the Efficacy and Safety of Initial Combination Therapy With DWP16001 and DWC202518 Compared to DWP16001 Monotherapy and DWC202518 Monotherapy in Patients With Type 2 Diabetes MellitusNot yet recruitingNCT07619833Phase 3
• Fexuclue for Prevention of NSAIDs-Induced Peptic Ulcer in Real-World PracticeNot yet recruitingNCT07558707
• A Phase 1 Clinical Trial to Assess the Safety of DWRX5003 and Relative Bioavailability to DWC202502 and DWC202503 in Healthy Adult VolunteersRecruitingNCT07539415Phase 1
• Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic UlcerNot yet recruitingNCT07533266Phase 4
• Noseguard for Prevention of Respiratory Infections in Real-World UseNot yet recruitingNCT07516977Not applicable
• Observational Study to Evaluate the Efficacy of OLMETEC Tab on Nocturnal Blood Pressure Control in Patients With Stage Ⅰ HypertensionRecruitingNCT07515599
• Efficacy and Safety of Baroezet Tablet in Korean Patients With Dyslipidemia: A Prospective Observational StudyNot yet recruitingNCT07515560
• Bioequivalence Study of DWZ2501 in Patients With Advanced BRCA-mutated High-grade Ovarian CancerRecruitingNCT07371104Phase 1
• Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy Volunteers Under Fed Condition.RecruitingNCT07267221Phase 1
• Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1622, DWC202313, and DWC202314 in Healthy Volunteers Under Fasting ConditionsRecruitingNCT07260851Phase 1
• Phase 4 Multicenter, Open-label Study on Efficacy and Safety of Apremilast in Moderate-to-severe PsoriasisNot yet recruitingNCT07190391
• PK and Safety Comparison of DWJ1511 and DWC202501 in Healthy VolunteersRecruitingNCT07144176Phase 1
• Evaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar LinesNot yet recruitingNCT07013279Phase 3
• Efficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic GastritisRecruitingNCT06948487
• Phase 1 Clinical Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP212525 in Healthy VolunteersRecruitingNCT06736587Phase 1
• Evaluation of Enavogliflozin's Efficacy and Safety in Type II Diabetes With Hypertension or DyslipidemiaRecruitingNCT06647888
• Phase 1 Study of Drug-Drug Interactions Between DWP16001, DWC202407, and DWC202408 in Healthy AdultsNot yet recruitingNCT06644404Phase 1
• Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment PatientsNot yet recruitingNCT06606093Phase 3
• Bioepuivalence Study for the Safety and the Pharmacokinetics of DWJ1589 and DWC202315Not yet recruitingNCT06592495Phase 1
• A MAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers and PHN Patients.RecruitingNCT06218784Phase 1
• Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes MellitusNot yet recruitingNCT06141980Phase 3
• Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non-Erosive Gastroesophageal Reflux Disease (NERD)RecruitingNCT06121830Phase 3
• Drug-drug Interactions Between DWC202313 and DWC202314 in Healthy SubjectsRecruitingNCT06119958Phase 1
• Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1568 in Healthy Adult VolunteersRecruitingNCT06119945Phase 1
• Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1567 in Healthy Adult VolunteersRecruitingNCT06109259Phase 1
• Evaluate the Efficacy and Safety of DWJ108JRecruitingNCT06025409Phase 3
• Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1543 With DWC202307 in Healthy Adult VolunteersNot yet recruitingNCT05954338Phase 1
• Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1543 in Healthy Adult VolunteersNot yet recruitingNCT05954247Phase 1
• To Evaluate the Effect of Food on the Safety and PK Characteristics of DWP16001 in Healthy Adult VolunteersRecruitingNCT05797922Phase 1
• To Compare the Safety and PK/PD Characteristics of Subjects With Between Hepatic Impairment and Normal Hepatic FunctionRecruitingNCT05747664Phase 1
• A Study to Investigate the Effect of DWP16001 as add-on Therapy to Drug A in Patients With Type 2 Diabetes MellitusRecruitingNCT05466643Phase 3
• Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's DiseaseRecruitingNCT05383183Phase 4
• A Study Assessing the Safety of Oral ATH-399A in Healthy Adult ParticipantsCompletedNCT06088784Phase 1Results posted
• A Study to Assess the Efficacy and Safety of Tanfanercept (HL036) Ophthalmic Solution in Participants With Dry EyeCompletedNCT05109702Phase 3Results posted
• A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry EyesCompletedNCT03846453Phase 3Results posted
• A Study to Assess Efficacy of HL036 in Subjects With Dry EyesCompletedNCT03334539Phase 2Results posted
• Functional Outcomes After Hyaluronic Acid Injections Following ArthroscopyCompletedNCT07468045Not applicable
• Allogeneic Human Mesenchymal Stem Cell Infusion for Frailty PatientCompletedNCT07449364Not applicable
• PK and Safety Comparison of DWJ445 and DWC202506 in Healthy VolunteersCompletedNCT07256600Phase 1
• Drug-Drug Interaction Study to Evaluate the Effect of DWC202511 or DWC202512 With DWP16001 in Healthy AdultsCompletedNCT07213310Phase 1
• Efficacy and Safety of Leuprolide Acetate 45 mg in Subjects With Central Precocious PubertyActive, not recruitingNCT06926933Phase 4
• To Investigate Blood Lipid Changes and Safety After Litorvazet® Tablets in Dyslipidemia PatientsCompletedNCT06866509
• Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter PyloriCompletedNCT06751121Phase 3
• Efficacy and Safety of DWC202404 and DWC202314 in Patients With HypertensionCompletedNCT06682000Phase 3
• A Phase III Study to Efficacy and Safety of DWC202405/DWC202313 and DWC202314 in Patients With HypertensionCompletedNCT06671392Phase 3
• To Evaluate Improvement Effect of Subjective Symptoms of Mucotra SR Tablet in Patients With GastritisCompletedNCT06668506
• Study to Evaluate the Safety/Tolerability, PK and PD After Intravenous DWJ1521 Administration in Healthy VolunteersCompletedNCT06508645Phase 1
• to Evaluate the Safety/Tolerability and Pharmacokinetics, and Pharmacodynamics of DWP14012 InjectionStatus unknownNCT06437951Phase 1
• Registry Study to Determine the Effectiveness and Safety of Weight Loss With Enavogliflozin in Patients With Type 2 Diabetes MellitusActive, not recruitingNCT06427083
• Effect of Linking Data Using Smartphone Application, 'Well Check', on Clinical Outcomes in Patients With Type 2 Diabetes MellitusActive, not recruitingNCT06419816
• A Study to Evaluate the Efficacy and Safety of Tanfanercept (HL036) in Dry Eye DiseaseSuspendedNCT06400589Phase 3
• DWP450 for Treating Moderate to Severe Glabellar LinesCompletedNCT06354127Phase 3
• Study to Evaluate the Efficacy and Safety of DWJ1464 in Patients with Chronic Liver DiseaseCompletedNCT06272630Phase 4
• Evaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar LinesCompletedNCT06212960Phase 1
• Efficacy and Safety of DWJ1609 for Bowel Cleansing Before Colonoscopy;CompletedNCT06062030Phase 3
• Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1558 in Healthy Adult VolunteersActive, not recruitingNCT06010589Phase 1
• Efficacy and Safety of Switching to Vemliver From Entecavir in Chronic Hepatitis B Patients Previously Treated With EntecavirCompletedNCT06000657Phase 4
• To Evaluate the Efficacy and Safety of Envlo Tablet or Envlomet SR Tablet in Patients With Type II Diabetes MellitusActive, not recruitingNCT05926414
• A Study to Evaluate the Efficacy and Safety of CREZET TabletActive, not recruitingNCT05889143
• Study to Evaluate the Efficacy and Safety of FEXUCLUE TabletCompletedNCT05886933
• A Clinical Study to Investigate the Mass Balance and Biotransformation of [14C]DWP14012 in Healthy Chinese Male SubjectsActive, not recruitingNCT05868967Phase 1
• An Exploratory Clinical Trial to Evaluate and Compare Safety and Pharmacokinetic Characteristics After Administration of the DWJ1439, DWJ1464, DWC202108 or DWC202109 in Healthy Adult VolunteersCompletedNCT05832697Phase 1
• Assessment of Elemental Impurities Level After Multiple Administration of DWJ1230 or DWB2001 in Subjects With Functional Diarrhea or Irritable Bowel Syndrome With Predominant Diarrhea.CompletedNCT05816681Phase 1
• The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux EsophagitisCompletedNCT05813561Phase 3
• Phase 1 Clinical Trial to Evaluate the Effect of DWP14012 on the Pharmacokinetics of DWC202201 in Healthy SubjectsStatus unknownNCT05812404Phase 1
• To Compare the Pharmacokinetic Characteristics of the Fixed-dose Combination Compared to the Loose CombinationStatus unknownNCT05737771Phase 1
• Drug-drug Interactions Between DWC202211 and DWC202212 in Healthy SubjectsStatus unknownNCT05699070Phase 1
• Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With DyslipidemiaActive, not recruitingNCT05660135
• A Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE TabCompletedNCT05660122
• A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and HyperlipidemiaCompletedNCT05643508Phase 3
• Study to Investigate the Efficacy and Safety After Administration of Daewoong Zoledronic Acid for the Purpose of Treatment or Prevention of OsteoporosisCompletedNCT05614778
• Evaluation of Dyslipidemia Management After Statin and Ezetimibe Complex TreatmentActive, not recruitingNCT05614765
• Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE TabCompletedNCT05614752
• The Safety, Tolerability, PK, and PD of DWP213388 After SAD and MAD Administration in Healthy Adult SubjectsWithdrawnNCT05607589Phase 1
• Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy SubjectsCompletedNCT05574374Phase 1
• The Efficacy and Safety of DWP16001 in Combination With Metformin in T2DM Patients Inadequately Controlled on MetforminActive, not recruitingNCT05505994Phase 3
• Drug-Drug Interaction of DWP16001 in Combination With DWC202204 and DWC202205 in Healthy Male AdultsStatus unknownNCT05500898Phase 1
• A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy VolunteersCompletedNCT05496205Phase 1
• Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics of DWP16001 Drug A and CCompletedNCT05465668Phase 1
• The Clinical Study to Evaluate Immunogenicity of Epodion® in Anemia Associated With CKD PatientsCompletedNCT05422755
• Pharmacokinetics and Safety Following Administration of DWP16001CompletedNCT05414591Phase 1
• Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar TabActive, not recruitingNCT05411887
• To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After GasterectomyCompletedNCT05410535Phase 4
• Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPFActive, not recruitingNCT05389215Phase 2
• DWP708 for Treating Epidermal Growth Factor Receptor Inhibitor Related Skin ToxicitiesCompletedNCT05378360Phase 2
• Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on MetforminCompletedNCT05376969Phase 3
• Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM.CompletedNCT05376930Phase 3
• The Clinical Study for Evaluating The Safety And Efficacy Of Epodion®CompletedNCT05373303Not applicable
• Efficacy and Safety Evaluation of EASYEF® in Acute Wound (Split-thickness Skin Graft Donor Site)CompletedNCT05335720Not applicable
• The Drug Interaction of DWP16001 and DWC202010 After Oral Administration in Healthy AdultsStatus unknownNCT05321732Phase 1
• Drug-drug Interactions Between DWP14012 and Aspirin in Healthy SubjectsCompletedNCT05304845Phase 1
• Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients.TerminatedNCT05226533Phase 2
• Pharmacokinetics, Safety, and Tolerability of rhEGF Eye Drops in Healthy Male SubjectsCompletedNCT05219461Phase 1
• Study to Evaluate the Safety and PK Properties of DWP16001 in Healthy Subjects With Various EthnicitiesStatus unknownNCT05207176Phase 1
• A Crossover Study of DWJ1525 to Evaluate the Safety and Pharmacokinetic Properties in Healthy VolunteersCompletedNCT05192395Phase 1
• Observational Study to Evaluate the Therapeutic Effectiveness and Safety of Olomax TabCompletedNCT05184179
• Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy SubjectsCompletedNCT05149274Phase 1

← Daewoong Pharmaceutical Co. LTD. overview and focus areas